ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30

Lucila N Kerbauy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.